Skip to content

The Street’s Cramer Interviews Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO: YouTube

October 16, 2012

     TheStreet.com’s Cramer interviews Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, on YouTube. 

      The Novato, California company, BioMarin, has the following orphan drugs on the market in the United States : 

1)  Kuvan (Sapropterin Dihydrochloride) for the treatment of Phenylketonuria (PKU)  

2)  Naglazyme (Galsulfase) for the treatment of Mucopolysaccharidosis VI (MPS VI)    

3)  Aldurazyme (Laronidase) for the treatment of Mucopolysaccharidosis I (MPS I). 

Reference 

BioMarin Pharmaceutical Pipeline  

Copyright  © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: